This is a preview of subscription content, log in via an institution to check access.
References
Lane DP. p53, Guardian of the genome. Nature 1992;358:15–6.
Canadian Task Force on the Periodic Health Examination. The periodic health examination. Version 1989. Available at: http://www.ctfphc.org./methods.htm. Accessed December 7, 2000.
DiGuiseppi C, Atkins D, Woo SH, eds. (US Preventive Services Task Force). Guide to clinical preventive services (CPS). 2nd ed. Alexandria, VA: International Medical Publishing, 1996.
SIGN (Scottish Intercollegiate Guidelines Network), ed. An introduction to SIGN methodology for the development of evidence-based clinical guidelines. Edinburgh: SIGN Publ No. 39, 1999.
Hermanek P, Gospodarowicz MK, Henson DE, Hutter RV, Sobin LH (International Union Against Cancer (UICC)), eds. Prognostic factors in cancer. Berlin: Springer, 1995.
Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP, American Joint Committee on Cancer Prognostic Factors Consensus Conference. Colorectal Working Group. Cancer 2000;88:1739–57.
Hermanek P. Prognostic factor research in oncology. J Clin Epidemiol 1999;52:371–4.
Hermanek P, Sobin LH, Wittekind Ch. How to improve the present TNM staging system [editorial]. Cancer 1999;86:2189–91.
Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. Br J Cancer 1994;69:979–85.
Author information
Authors and Affiliations
About this article
Cite this article
Hermanek, P. Invited editorial. Dis Colon Rectum 44, 333–334 (2001). https://doi.org/10.1007/BF02234728
Issue Date:
DOI: https://doi.org/10.1007/BF02234728